Gene expression changes caused by the p38 MAPK inhibitor dilmapimod in COPD patients: analysis of blood and sputum samples from a randomized, placebo-controlled clinical trial (Q41405454)
Jump to navigation
Jump to search
scientific article published on 9 December 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Gene expression changes caused by the p38 MAPK inhibitor dilmapimod in COPD patients: analysis of blood and sputum samples from a randomized, placebo-controlled clinical trial |
scientific article published on 9 December 2014 |
Statements
1 reference
Gene expression changes caused by the p38 MAPK inhibitor dilmapimod in COPD patients: analysis of blood and sputum samples from a randomized, placebo-controlled clinical trial (English)
1 reference
Ruth Tal-Singer
1 reference
Joanna C Betts
1 reference
Ruth J Mayer
1 reference
Linda Warnock
1 reference
Chris Clayton
1 reference
Stewart Bates
1 reference
Bryan E Hoffman
1 reference
Christopher Larminie
1 reference
Dave Singh
1 reference
9 December 2014
1 reference
1 reference
3
1 reference
1
1 reference
e00094
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference